DE60225841D1 - Neue stabile kristalle substituierter phenylpropionsäurederivate und verfahren zu deren herstellung - Google Patents

Neue stabile kristalle substituierter phenylpropionsäurederivate und verfahren zu deren herstellung

Info

Publication number
DE60225841D1
DE60225841D1 DE60225841T DE60225841T DE60225841D1 DE 60225841 D1 DE60225841 D1 DE 60225841D1 DE 60225841 T DE60225841 T DE 60225841T DE 60225841 T DE60225841 T DE 60225841T DE 60225841 D1 DE60225841 D1 DE 60225841D1
Authority
DE
Germany
Prior art keywords
production
acid derivatives
phenylpropionic acid
new stable
stable crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60225841T
Other languages
English (en)
Other versions
DE60225841T2 (de
Inventor
Kazuo Orita
Tomomi Koike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of DE60225841D1 publication Critical patent/DE60225841D1/de
Application granted granted Critical
Publication of DE60225841T2 publication Critical patent/DE60225841T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE60225841T 2001-12-11 2002-12-10 Neue stabile kristalle substituierter phenylpropionsäurederivate und verfahren zu deren herstellung Expired - Lifetime DE60225841T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001377077 2001-12-11
JP2001377077 2001-12-11
PCT/JP2002/012892 WO2003050077A1 (fr) 2001-12-11 2002-12-10 Cristaux stables de derive d'acide phenylpropionique substitue et procede de production associe

Publications (2)

Publication Number Publication Date
DE60225841D1 true DE60225841D1 (de) 2008-05-08
DE60225841T2 DE60225841T2 (de) 2009-05-14

Family

ID=19185129

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60225841T Expired - Lifetime DE60225841T2 (de) 2001-12-11 2002-12-10 Neue stabile kristalle substituierter phenylpropionsäurederivate und verfahren zu deren herstellung

Country Status (14)

Country Link
US (1) US7279596B2 (de)
EP (1) EP1462439B1 (de)
JP (1) JP4424728B2 (de)
KR (1) KR100876849B1 (de)
CN (1) CN1312121C (de)
AT (1) ATE390406T1 (de)
AU (1) AU2002349538B2 (de)
CA (1) CA2469882C (de)
CY (1) CY1107417T1 (de)
DE (1) DE60225841T2 (de)
DK (1) DK1462439T3 (de)
ES (1) ES2302857T3 (de)
PT (1) PT1462439E (de)
WO (1) WO2003050077A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515015A (pt) 2004-08-11 2008-07-01 Kyorin Seiyaku Kk derivado cìclico de ácido aminobenzóico; medicamento; agonista ppar(alpha); agonista duplo ppar(alpha), y; agonista duplo ppar(alpha), (delta); modulador ppar; agente lipìdeo; agente profilático ou terapêutico compreendendo pelo menos um dos derivados cìclicos de ácido aminobenzóico ou sal do mesmo farmacêuticamente aceitável
JP2007001912A (ja) * 2005-06-22 2007-01-11 Univ Of Tokyo 置換フェニルプロピオン酸誘導体
CA2669849C (en) * 2006-12-06 2012-01-31 Pfizer Inc. Crystalline forms of (3s)-3-[n-(n'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4618845B2 (ja) * 1999-06-09 2011-01-26 杏林製薬株式会社 ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
EP1219595B1 (de) * 1999-09-17 2006-01-18 Kyorin Pharmaceutical Co., Ltd. O-anisamid-derivate
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives

Also Published As

Publication number Publication date
US20050228050A1 (en) 2005-10-13
ATE390406T1 (de) 2008-04-15
AU2002349538A1 (en) 2003-06-23
EP1462439A1 (de) 2004-09-29
KR20040075000A (ko) 2004-08-26
AU2002349538B2 (en) 2006-04-27
CA2469882C (en) 2009-09-29
US7279596B2 (en) 2007-10-09
CA2469882A1 (en) 2003-06-19
EP1462439B1 (de) 2008-03-26
DK1462439T3 (da) 2008-04-21
CN1602295A (zh) 2005-03-30
CY1107417T1 (el) 2012-12-19
CN1312121C (zh) 2007-04-25
ES2302857T3 (es) 2008-08-01
EP1462439A4 (de) 2006-02-01
DE60225841T2 (de) 2009-05-14
WO2003050077A1 (fr) 2003-06-19
PT1462439E (pt) 2008-04-10
JP4424728B2 (ja) 2010-03-03
JPWO2003050077A1 (ja) 2005-04-21
KR100876849B1 (ko) 2008-12-31

Similar Documents

Publication Publication Date Title
ATE440817T1 (de) Bicalutamidkristalle und verfahren zu deren herstellung
CA2334775A1 (en) Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
ATE448225T1 (de) Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten
ATE260896T1 (de) Donepezil polykristalle und verfharen zu ihrer herstellung
DE3854280D1 (de) Neue cyclische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung.
BRPI0613418A2 (pt) processo de preparo da 4ß- amino -4'demetil-4-deoxipodofilo toxina
TR200102771T2 (tr) Kristalleştirme ile elde edilen aglomeralar
DE3667660D1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
ATE390406T1 (de) Neue stabile kristalle substituierter phenylpropionsäurederivate und verfahren zu deren herstellung
ATE59378T1 (de) Neue naphtalin- und indanderivate, diese verbindungen enthaltende arzneimittel und verfahren zu deren herstellung.
WO2001098265B1 (en) Process for isolating enantiomers of racemic cetamine
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
DE3280245D1 (de) Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
FR2846325B1 (fr) Nouveau procede de preparation d'un intermediaire de synthese de pesticide
ATE382624T1 (de) Kristalle von taxanderivaten und verfahren zu deren herstellung
CA2363875A1 (en) Method crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide
DE60133995D1 (de) Neues kristallines stilben-derivat und verfahren zu dessen herstellung
DK527483D0 (da) Fremgangsmade til fremstilling af benzazepinderivater
ATE123776T1 (de) Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater
DK158661C (da) Analogifremgangsmaade til fremstilling af benzamido-alkyl-hydroxamsyrederivater.
DE50000808D1 (de) Verfahren zur Herstellung von 3-Isochromanonen durch Cyclisierung von o-Chlormehtylphenylessigsäuren
ATE155783T1 (de) Neue thiophen-2-carbonsäurederivate und verfahren zu deren herstellung
ATE32719T1 (de) Neues nortropinderivat, verfahren zu seiner herstellung und seine verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition